10x Genomics Forecasts 2026 Revenue Between $625M and $635M Amid Atera Shipments
10x Genomics (TXG) reported third-quarter revenue of $151 million, representing a 1% increase year-over-year. The company's management highlighted the commencement of commercial shipments for its new Atera platform as a primary driver for future growth. Looking ahead to 2026, the company has provided a revenue guidance range of $625 million to $635 million. To support this trajectory, 10x Genomics is targeting approximately 50 Atera shipments by the end of the current year, signaling an aggressive push into commercializing its latest technology.
Tickers: $TXG